Eldon Biologicals A/S

Public limited companyCVR 26747007GentofteActive

Eldon Biologicals A/S is a public limited company, based in Gentofte, active in manufacture of other chemical products n.e.c., founded in 2002. Net profit rose 18% from 2019 to 2025, ending at DKK 3.9m. Equity grew to DKK 42.1m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 13.6m+43% vs. 2019
Net profitDKK 3.9m+17.8% vs. 2019
EquityDKK 42.1m+302.4% vs. 2019
Employees18latest month from CVR

What has changed

calculated from recorded figures and dates

Management and owners, last 24 months

  • Stepped down: Hans-Ole Hedegaard (board member, 26/07/2026).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2018–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 10mDKK 20mDKK 30mDKK 40m201820192025
EquityNet profit
Financial figures for Eldon Biologicals A/S
201820192025Change
Revenuenot statednot statednot stated–
Gross profit9,5209,53713,635+43%
Operating profit (EBIT)4,9744,2024,621+10%
Profit before tax4,8164,2545,024+18.1%
Net profit3,7553,3103,900+17.8%
Total assets12,37015,24547,875+214%
Equity7,14210,45242,056+302.4%
Liabilities5,0424,6525,026+8.1%
Cash and cash equivalents7,6398,43418,388+118%
Average number of employees7612+100%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2018, 2019, 2025: smaller companies may omit it, and we do not derive it from other figures. The register has no financial statements for 2020, 2021, 2022, 2023, 2024 (changed financial year or not filed).

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 2mDKK 4mDKK 6mDKK 8mDKK 10mDKK 12mDKK 14m201820192025
Gross profitMedian, the industry (29 companies)

Annual reports

3 financial years
Annual reports for Eldon Biologicals A/S
Financial yearPeriodPublishedFigures forDocuments
202501/07/2024 – 30/06/202512/12/2025The companyPDF not statedXBRL
201901/07/2018 – 30/06/201926/02/2020The companyPDFXBRL
201801/07/2017 – 30/06/201802/01/2019The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02468101214161809/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

29 companies in the database

Comparison with the other companies in manufacture of other chemical products n.e.c. based on the latest financial year.

Gross profitDKK 13.6mNo. 15 of 29
Better than 50% of the companies in the industry
EquityDKK 42.1mNo. 11 of 29
Better than 64% of the companies in the industry
Number of employees18No. 16 of 29
Better than 46% of the companies in the industry

Industry median: gross profit DKK 13.6m, net profit DKK 2.4m, equity DKK 16.4m, 14 employees.

DKK 1.1mDKK 8.7mDKK 69.5mDKK 555.3mDKK 2.2bnHere
Distribution of gross profit for 26 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 2,840of 69,742
Better than 96%
No. 3,504of 69,964
Better than 95%
Same industry and fewer than 20 employees17 companies in the comparison
No. 5of 17
Better than 75%
No. 2of 17
Better than 94%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 4,686of 24,791
Better than 81%
No. 2,662of 24,909
Better than 89%
All companies of type A/S18,025 companies in the comparison
No. 7,615of 17,786
Better than 57%
No. 4,003of 18,024
Better than 78%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of other chemical products n.e.c.
Gross profit
  1. Eldon Biologicals A/SDKK 13.6m
  2. Chr. Hansen A/SDKK 4.4bn
  3. International N&H Denmark ApSDKK 889m
Net profit
  1. Eldon Biologicals A/SDKK 3.9m
  2. Chr. Hansen A/SDKK 2.1bn
  3. International N&H Denmark ApSDKK 1.4bn
Equity
  1. Eldon Biologicals A/SDKK 42.1m
  2. Chr. Hansen A/SDKK 11.3bn
  3. International N&H Denmark ApSDKK 4.2bn
Employees
  1. Eldon Biologicals A/S18
  2. Chr. Hansen A/S1,747
  3. International N&H Denmark ApS1,022

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Medi-trade ApS33.33%
  • Holdingselskabet Mlh ApS50%
Eldon Biologicals A/S

Management

4 active registrations

Executive management

Executive management at Eldon Biologicals A/S
NameRoleAppointed
Kasper Juul HedegaardCEO01/12/2020

Board of directors

Board of directors at Eldon Biologicals A/S
NameRoleAppointed
Michael Lützhøft HansenChair of the board10/08/2002
Kasper Juul HedegaardBoard member17/08/2012
Cara Beth SeidermanBoard member17/08/2012
Founders
Michael Lützhøft Hansen, Hans-Ole Hedegaard
Former management (3)
Former management at Eldon Biologicals A/S
NameRoleAppointedResigned
Hans Josef WilmsBoard member10/08/200217/08/2012
Hans-Ole HedegaardBoard member10/08/200226/07/2026
Hans-Ole HedegaardDirector10/08/200201/12/2020

Signing rule: Selskabet tegnes af direktøren og et medlem af bestyrelsen eller af den samlede bestyrelse.

Address and production units

1 active production units

Sandtoften 10
2820 Gentofte

Gentofte Municipality · Postcode 2820

Other companies at the address (2)

Production units
Production unitAddressEmployeesP number
ELDON BIOLOGICALS A/SSandtoften 10, 2820 Gentofte181009275270

Purpose

Selskabets formål er udvikling, fremstilling og salg af produkter og tjenesteydelser til sundhedssektoren, herunder investering og hermed beslægtet virksomhed i sundhedssektoren og andre relevante sektorer.

The purpose is quoted from the register in Danish.

Changes year by year

22 registered events
20261 changemanagement 1
  • Hans-Ole Hedegaard stepped down as board member
20251 changeaccounts 1
  • Annual report for 2025 published
20231 changeindustry 1
  • Industry changed to Manufacture of other chemical products n.e.c. (205900)
20203 changesmanagement 2 · accounts 1
  • Kasper Juul Hedegaard appointed ceo
  • Hans-Ole Hedegaard stepped down as director
  • Annual report for 2019 published
20191 changeaccounts 1
  • Annual report for 2018 published
20144 changesownership 4
  • Mads Juul Hedegaard registered as owner (10%)
  • Mads Juul Hedegaard is no longer registered as owner
  • Nicolai Juul Hedegaard registered as owner (10%)
  • Nicolai Juul Hedegaard is no longer registered as owner
20123 changesmanagement 3
  • Kasper Juul Hedegaard appointed board member
  • Cara Beth Seiderman appointed board member
  • Hans Josef Wilms stepped down as board member
20081 changeindustry 1
  • Industry changed to Manufacture of pharmaceutical preparations (212000)
20027 changesownership 2 · founded 1 · management 4
  • HOLDINGSELSKABET MLH ApS registered as owner (50%)
  • Registered as ELDON BIOLOGICALS A/S
  • Hans-Ole Hedegaard appointed board member
  • Michael Lützhøft Hansen appointed chair of the board
  • Hans-Ole Hedegaard appointed director
  • Hans Josef Wilms appointed board member
  • MEDI-TRADE ApS registered as owner (33.33%)

Related companies

Same people in management

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction